Kyowa Kirin Co. Ltd. Stock

Equities

4151

JP3256000005

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-06-14 EDT 5-day change 1st Jan Change
2,748 JPY +2.29% Intraday chart for Kyowa Kirin Co. Ltd. +1.59% +15.93%

Financials

Sales 2024 * 473B 3.01B 4.13B Sales 2025 * 485B 3.08B 4.23B Capitalization 1,455B 9.24B 12.69B
Net income 2024 * 66.65B 423M 581M Net income 2025 * 72.49B 460M 632M EV / Sales 2024 * 2.38 x
Net cash position 2024 * 328B 2.08B 2.86B Net cash position 2025 * 360B 2.29B 3.14B EV / Sales 2025 * 2.26 x
P/E ratio 2024 *
21.9 x
P/E ratio 2025 *
20.1 x
Employees 5,974
Yield 2024 *
2.13%
Yield 2025 *
2.23%
Free-Float 45.41%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.29%
1 week+1.59%
Current month+3.46%
1 month+4.11%
3 months-2.92%
6 months+13.91%
Current year+15.93%
More quotes
1 week
2 651.00
Extreme 2651
2 756.50
1 month
2 536.00
Extreme 2536
2 756.50
Current year
2 266.50
Extreme 2266.5
3 009.00
1 year
2 266.50
Extreme 2266.5
3 009.00
3 years
2 266.50
Extreme 2266.5
4 240.00
5 years
1 674.00
Extreme 1674
4 240.00
10 years
1 094.00
Extreme 1094
4 240.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 86-03-31
President 64 85-03-31
Chief Tech/Sci/R&D Officer 62 10-03-31
Members of the board TitleAgeSince
Director/Board Member 68 21-02-28
Director/Board Member 69 22-02-28
Director/Board Member 66 08-09-30
More insiders
Date Price Change Volume
24-06-14 2,748 +2.29% 2,426,300
24-06-13 2,686 -0.26% 702,800
24-06-12 2,693 -1.23% 1,014,200
24-06-11 2,726 -0.04% 697,400
24-06-10 2,728 +0.85% 817,300

Delayed Quote Japan Exchange, June 14, 2024 at 02:00 am

More quotes
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows: - sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment; - sales of licenses (7.4%). At the end of 2021, the group had 3 production sites located in Japan (2) and China. Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,748 JPY
Average target price
3,054 JPY
Spread / Average Target
+11.16%
Consensus